Korea Biochem Pharm has passed the actual inspection of TEVA on component manufacturing facilities

Korea Biochem Pharm, a branch of Korea United Pharm (president Duk-young Kang), has passed an actual inspection of TEVA on manufacturing facilities.

As making a contract with an Israel global pharmaceutical company, TEVA,to sell its first self-developed drug ‘Clanza CR Tab’in Russia and Eastern Europe countries on the 2^nd, United Pharm made an additional contract to sell a technology in the Ve...